Personal Homepage

of VANDER STICHELE Robert, MD

Scientific activities


Created 19/06/1995 / Last modified 15/06/2004
VANDER STICHELE Robert
Heymans Institute of Pharmacology, Medical School, University of Gent De Pintelaan 185, B-9000 Gent, Belgium Tel. : 00 32 9 240 33 36
Fax. : 00 32 9 240 49 88
E-mail : robert.vandersti chele@ugent.be
WWW : http:/allserv.rug.ac.be/~rvdstich/

PUBLICATIONS, Robert H. VANDER STICHELE


JOURNAL ARTICLES AND BOOK CHAPTERS


R. H. Vander Stichele, M. M. Elseviers, M. Ferech, S. Blot, H. Goossens, the ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): Data Collection Performance and Methodological Approach. British Journal of Clinical Pharmacology. Online publication date: 21-Jun-2004. doi: 10.1111/j.1365-2125.2004.02164.x

Bilsen J, Vander Stichele R, Mortier F, Bernheim J, Deliens L. The incidence and characteristics of end-of-life decisions by GPs in Belgium. Family Practice 2004; 21(3):282-289.

Vander Stichele RH, Bilsen JJR, Bernheim JL, Mortier F, Deliens L. Drugs used for euthanasia in Flanders, Belgium. Pharmacoepidemiology and Drug Safety 2004; 13(2):89-95.

Deliens L, Ganzini L, Vander Stichele R. The use of drugs to hasten deaths. Pharmacoepidemiology and Drug Safety 2004; 13(2):113-114. 1.257)

Mortier E, Bilsen J, Vander Stichele RH, Bernheim J, Deliens L. Attitudes, sociodemographic characteristics, and actual end-of-life decisions of physicians in Flanders, Belgium. Medical Decision Making 2003; 23(6):502-510.

Vander Stichele R. Information retrieval skills of researchers in general practice.Eur J Gen Pract. 2003;9:75-6.

Lapeere H, Vander Stichele RH, Naeyaert JM. Evidence in the treatment of head lice: Drowning in a swamp of reviews. Clinical Infectious Diseases 2003; 37(11):1580-1582. . 5.393)

Ronning M, Blix HS, Strom H, Skovlund E, Andersen M, Vander Stichele R. Problems in collecting comparable national drug use data in Europe: the example of antibacterials. European Journal of Clinical Pharmacology 2003; 58(12):843-849.

Rosian I, Vogler S, Vander Stichele R, Larsen L, Odegaard B, Brahm AK et al. EURO-MED-STAT - Monitoring expenditure and utilization of medicinal products in the European Union countries: a Public Health approach. European Journal of Public Health 2003; 13:95-100.

Ferech M, Elseviers M, Vander Stichele R, Goossens H. Consumption of antibiotics in Europe: Results of the ESAC retrospective data collection. Value in Health 2003; 6(6):746.

Vander Stichele RH. Bridging the gap between research and policy: focusing the patient. European Journal of Public Health 2002; 12(4):31.

Vander Stichele RH, Peys F, Van Tielen R, Van Eeckhout H, van Essche O, Seys B. A decade of growth in public and private pharmaceutical expenditures: The case of Belgium 1990-1999. Acta Clinica Belgica 2003; 58(5):279-289.

LeLorier J, Vander Stichele RH, Avorn J, Beard K, Hallas J, Henry DA. Bringing epidemiology into drug utilisation research. Pharmacoepidemiology and Drug Safety 2003; 12(2):153-156.

Vander Stichele RH, Van Dierendonck A, De Vooght G, Reynvoet B, Lammertyn J. Impact of benefit messages in patient package inserts on subjective drug perception. Drug Inform J 2002;26:201-208.

Vander Stichele RH, Gyssels L, Bracke C, Meersschaut F, Blokland I, Wittouck E, Willems S, De Maeseneer J. Wet combing for head lice: feasibility in mass screening, treatment preference and effectiveness. J Roy Soc Med (Accepted).

Deschepper R, Vander Stichele RH, Haaijer-Ruskamp FM. Cross-cultural differences in lay-attitudes and utilisation of antibiotics in a Belgian and a Ducth City. Pat Educ Couns (accepted).

Verstraete AG, Vander Stichele RH, Deliens HJ. Ethical issues in pharmacoepidemiological research in Belgium. Pharmacoepidemiol Drug Saf 2001;10:595-599.

De Backer TL, Vander Stichele RH, Bogaert MG. Buflomedil for intermittent claudication. Cochrane Database Syst Rev 2001;(1):CD000988.

Deliens L, Mortier F, Bilsen J, Cosyns M, Vander Stichele R, Vanoverloop J, Ingels K, Bernheim J. [Euthanasia and other medical decisions concerning the end of life in Belgium: epidemiologic studies] Rev Med Liege. 2001 Jun;56(6):443-52. (French).

De Backer TL, Vander Stichele RH, Warie HH, Bogaert MG. Oral Vasoactive medications intermittent claudication: utile of futile? Eur J Clin Pharmacol 2000;56:199-206.

Deliens L, Mortier F, Bilsen J, Cosyns M, Vander Stichele R, Vanoverloop J, Ingels K. End-of-life decisions in medical practice in Flanders, Belgium: a nationwide survey. Lancet. 2000;356:1806-11.

Mortier F, Deliens L, Bilsen J, Cosyns M, Ingels K, Vander Stichele R. End-of-life decisions of physicians in the city of Hasselt (Flanders, Belgium). Bioethics 2000;14:254-267.

De Maeseneer J, Blokland I, Willems S, Vander Stichele R, Meersschaut F. Wet combing versus traditional scalp inspection to detect head lice in schoolchildren: observational study. BMJ. 2000;321:1187-8.

Pan L, Vander Stichele R, Rosseel MT, Berlo JA, De Schepper N, Belpaire F. Effects of smoking, CYP2D6 genotype and concomitant drug intake in the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients. Ther Drug Mon 1999;21:489-497.

Van Wynckel M, Vander Stichele R, De Bacquer D, Bogaert MG. Use of laxatives in institutions for the mentally retarded. Eur J Clin Pharmacol 1999;54:965-69.

De Sutter K, Vander Stichele R, Vander Stichele RH, Robays H. [Follow up of quality of drug distribution systems in the hospital]. Hospitalia, 1998;1:38-49.

Vander Stichele RH. [Polypharmacy in the elderly]. Bijblijven 1998;2:43-42 (Dutch).

Vander Stichele RH, De Potter B, Vyncke P, Bogaert MG. Attitude of physicians toward patient package inserts for medication in Belgium. Pat Educ Counsel 1996;28:5-13.

Vander Stichele RH, Bogaert MG. Topical treatments for head lice. Authors' reply. [Comment] BMJ 1996;312:123.

Vander Stichele RH, Bogaert MG. Clinical efficacy of treatment of head lice. Authors reply. [Comment] BMJ 1995;311:1369- 1370

Vander Stichele RH, Dezeure E, Bogaert MG. A systematic review of clinical efficacy of topical treatments of head lice. BMJ 1995;311:604-8.

Vander Stichele RH, Petri H. Utilization of subsidized and nonsubsidized reimbursable peptic ulcer medication in Belgium. Pharmacoepidemiology and Drug Safety 1995;4:213-24.

Bogaert MG, Vander Stichele R. [Factors influencing medication prescription]. Louvain Med 1995;114:320-324.(French).

Vander Stichele RH, Bogaert MG. Pediculus Humanus Capitits in schoolchildren [letter]. Lancet 1995;345:731.

Vander Stichele RH, Bogaert MG. European legislation and research projects regarding patient education for medication. Drug Inform J 1995;29:285-290.

Bogaert MG, Vander Stichele R. Drug treatment: risk perception by the public and the health professionels. Eur J Clin Res 1994;6:203-13.

Bogaert MG, Vander Stichele R. [Pharmacokinetics and Pharmacodynamics of cardiovascular drugs in women]. Tijdschr Geneesk 1994;50:989-992 (Dutch).

Bogaert MG, Vander Stichele R. [Medication usage by the elderly]. Tijdschr voor Geneeskunde 1993;49:1668-1670.

Vander Stichele RH, Mestdagh J, Van Haecht CHM, De Potter B, Bogaert MG. [Medication utilization and patient information in homes for the aged]. Huisarts Nu 1993;23:10-16 (Dutch).

Vander Stichele RH. [Studies on the interface between primary care and hospital in medication utilization]. Pharmacon 1992;92:139-145 (Dutch).

Petri H, Vander Stichele R, Cuypers J. [Use of reimbursed anti ulcer therapy]. Apothekersblad 1992(12):16-21 (Dutch).

Vander Stichele RH, Thomson M, Verkoelen K, Droussin AM. Measuring patient compliance with electronic monitoring: lisinopril versus atenolol in essential hypertension. Post Marketing Surveillance 1992;6:77-90.

De Cort P, Vander Stichele R, Janssen M, Heyrman J. [Quality of life in hypertensive patients]. Huisarts Nu 1992;22:378-382. (Dutch).

Vander Stichele RH, Van Elsen J, Lannoy J, Riebbels G. [Interprofessional relations between general practititioners and other health professionals in an urban region.] Tijdschr Geneeskd 1992;48:847-855) (Dutch).

Vander Stichele RH, Mestdagh J, Van Haecht CHM, De Potter B, Bogaert MG. Medication utilization and patient information in homes for the aged. Eur J Clin Pharmacol 1992;43:319-321

Vander Stichele RH, Van Haecht CH, Braem MD, Bogaert MG. Attitude of the public towards technical package inserts for medication information in Belgium. DICP 1991;25:1002-1006.

Vander Stichele R. Measurement of patient compliance and the interpretation of randomized clinical trials. Eur J Clin Pharmacol 1991;41:27-35.

Van haecht CHM, Vander Stichele R, De Backer G, Bogaert MG. Impact of Patient Package Inserts on Patients' Satisfaction, Adverse Drug Reactions and Risk Perception: The Case of NSAIDs for posttraumatic Pain Relief. Pat Educ Counsel 1991;17:205- 215.

Staessen J, Bogaert M, Clement D, Dekempeneer L, De Plaen JF, Fagard R, Heyrman J, Lijnen P, Pelemans W, Thijs L, Vander Stichele R, Van Hoof R, Amery A. [Isolated Systolic Hypertension in the elderly. Part I : Epidemiology, pathophysiology and diagnosis. Tijdschr Geneeskd 1991;47:561- 570 (78 ref.) (Dutch).

Staessen J, Bogaert M, Clement D, Dekempeneer L, De Plaen JF, Fagard R, Heyrman J, Lijnen P, Pelemans W, Thijs L, Vander Stichele R, Van Hoof R, Amery A. [Isolated Systolic Hypertension in the elderly. Treatment]. Tijdschr Geneeskd 1991;47:609-619 (97 ref.) (Dutch).

Vander Stichele R. Patient package inserts: carriers of consensus information. In: Dinkel R, Horisberger B, Tolo KW (eds). Improving drug safety - a joint responsability. Berlin: Springer-Verlag, 1991:151-155.

Van haecht CHM, Vander Stichele R, Bogaert MG. Package inserts for antihypertensive drugs: use by the patients and impact on adverse drug reactions. Eur J Clin Pharmacol 1990:39:551-554.

Vander Stichele R, Bogaert MG. Patient package inserts: the Belgian experience with a mandatory program. Drug Inform J 1989;23:673-677.

Vander Stichele R. Patient package inserts as a source of drug information: review of the literature. In: Bogaert M, Vander Stichele R, Kaufman JM, Lefebvre R (eds). Patient package insert as a source of drug information. Amsterdam: Excerpta Medica, 1989:3-11.

Peeters C, Vander Stichele R. A training course in medical documentation for family physicians. In: Deschamps C, Walckiers M (eds). Medical libraries: cooperation and new technologies. Elsevier Science Publishers, North-Holland, 1987.

Vander Stichele RH, Verhellen E. [Medical Documentation for Family Physicians]. Part 2. Teacher's manual. State University of Gent, Department of Adult Education, 1986 (Dutch).

Vander Stichele RH, Verhellen E. [Learning to deal with scientific literature]. Proceedings of a symposium of the Belgian Fund for Scientific Research. State University of Gent, Department of Adult Education, 1985 (Dutch).

Verhellen E, Vander Stichele RH. [Medical Documentation for Family Physicians]. Part 1. Program report. State University of Gent, Department of Adult Education, 1985 (Dutch).

Vander Stichele R, Heyvaert J, Van Royen P, De Smet E. [Information channels to the flemish general practitioner]. Huisarts Nu, 1985;14(5):188-195 (Dutch).

Vander Stichele RH. [Zomepirac and anaphylaxis: a study of the role of medical literature in the reporting of serious side- effects of new medicines]. Huisarts Nu, 1983;12(5):164-166 (Dutch).

ACKNOWLEDGMENTS IN OTHER PUBLICATIONS

Detry JMR, Block P, De Backer G, De Gaute JP, Six R (The Belgian Collaborative Study Group). Patient compliance and therapeutic coverage: comparison of amlodipine and slow release nifedipine in the treatment of hypertension. Eur J Clin Pharmacol 1995;47:477-81.

Detry JMR, Block P, De Backer G, De Gaute JP, Six R (The Belgian Collaborative Study Group). Patient compliance and therapeutic coverage: amlodipine versus slow release nifedipine in the treatment of agina pectoris. J Int Med Res 1994;22:278-286.

EDITING OF BOOKS

De Schepper R, Vander Stichele R, Mortier F, Deliens L, Zorgzaam thuis sterven - Een zorgleidraad voor huisartsen. Gent, Academia Press, 2003 [Dutch]

Buntinx F, Vander Stichele R. Omgaan met medische documentatie en informatie. Leuven: ACCO, 1998 [Dutch].

Buntinx F, Vander Stichele R. Omgaan met medische documentatie en informatie. Antwerpen: Wetenschappelijke Vereniging van Vlaams Huisartsen Instituut, 1993 [Dutch].

Vander Stichele R, Van Peteghem S, Buntinx F (eds). [Medical and Nursing Libraries in Belgium]. Flemish Research Institute of Family Medicine, 1989 (Dutch).

Bogaert M, Vander Stichele R, Kaufman JM, Lefebvre R (eds). Patient package insert as a source of drug information. Amsterdam: Excerpta Medica, 1989.


CURRICULUM VITAE, Robert H. VANDER STICHELE


Robert H. VANDER STICHELE

Family Physician          Last Update : June 8th, 2002
                          Age 49 
                          Married (Van den Berghe Maria)
                          2 children

Heymans Institute of Pharmacology  Tel. : +32 9 240 33 36
De Pintelaan, 185                  Fax. : +32 9 240 49 88
B-9000 Gent                      
Belgium                          
                                 



EDUCATION

Medical Doctor, State University of Gent and Free University of Brussels, Belgium, 1977.

ECFMG-Certificate, Brussels, 1977.



MAIN OCCUPATION

February 1978 - Present :Practicing family physician in the city of Gent, Belgium.



EXPERIENCE


November 20001 - Present : Senior Researcher, Centre for Evidence Based Medicine, Belgian Branch of the Cochrane Collaboration, Ghent University.

October 2000 - Present : Senior Researcher, Guidelines for End-of-life decisions, Ghent University, Department of Philosophy.

April 1999 - Present : Coordinator of Information Technology Applications, Belgian Centre of Pharmacotherapeutic Information, Brussels.

March 2002 - January 2004 : Network Coordinator, European Surveillance of Antimicrobial Consumption, Departement of Microbiology, University of Antwerp.

July 1996 - July 2000 : Senior Researcher, Health Technology Assessment, Heymans Institute of Pharmacology and the Belgian Supreme Council for Health Care, Brussels.

October 1995 - June 1996 : Research Coordinator, Drug Utilization Review, Heymans Institute of Pharmacology, Ghent University.

January 1995 - September 1995 : Research Coordinator of the Institute of Pharmaco-epidemiology of Belgium, Brussels.

September 1993 - December 1994 : Coordinator of the Meta-analysis Project, Heymans Institute of Pharmacology, Ghent University.

March 1988 - August 1993 : Chief coordinator of the Belgian Patient Package Insert Evaluation Program, Heymans Institute of Pharmacology, Ghent University.

December 1987 - January 1991 : Proofreader of Patient Package Inserts for the Pharmaceutical Inspection of the Belgian Department of Health.

February 1986 - November 1987 : Special Advisor to the Belgian State Secretary of Health on biomedical ethical issues and medication information policy.

January 1984 - December 1985 : Chief coordinator of the educational research program "Bibliographic Instruction for Family Physicians", Department of Adult Education, State University of Gent.



PUBLIC SERVICE, Robert H. VANDER STICHELE





Member of the board of the European Drug Utilization Research Group (1996-present)

Member of the board of the Belgian Society of Pharmaco- epidemiology (1995-present)

Editorial Board, Patient Education and Counseling (1994-present)

Acting Secretary General, the Institute of Pharmacoepidemiology of Belgium (1990-1995).

Coordinator, the Medical Subject Headings Dutch Translation Program, Institute of Translators and Interpretors, Gent, Belgium (1988-present).

Visiting lecturer, Free University of Brussels, Masters & PhD Program of Pharmaceutical Medicine, partim "Drug Utilization Review" (1994-present).

Visiting lecturer, Medical School of the State University of Gent, on the subject of Medical Documentation (1986-present).

Acting Secretary General, the Flemish Research Institute of Family Medicine (1985-1995).

Editorial Board, Huisarts Nu (1985-1993).

Project Manager for the glossary of technical and popular medical terms in nine European languages, contracted by the Commission of the European Communities (DG III) (1993-1995)

Editiorial Board, Post Marketing Surveillance. An International Journal devoted to Pharmacoepidemiology. (1991-1994).

Coordinator, the European Directory of Medical Libraries Program, European Association of Health Information and Libraries (1989- 1990).

Copromotor of dissertations, the Postgraduate of Documentation and Library Science, University of Antwerp (1986-1988).

Reviewer for Patient Education and Counseling, British Journal of General Practice, Annals of Pharmacotherapy, Postmarketing Surveillance: the International Journal of Pharmacoepidemiology.





PARTICIPATIONS, Robert H. VANDER STICHELE



Participated at the Food and Drug Adminstration Patient Information Workshop (panel discussion), Washington DC, February 14-15, 1996.

Participated at the 3th annual Meeting of the Belgian Society for Pharmaco-epidemiology, Liege, Belgium, November 17, 1995.

Participated at the 2th annual Meeting of the Belgian Society for Pharmaco-epidemiology, Brussels, Belgium, November 19, 1994

Chaired a session at the 12th annual meeting of Flemish General Practice Research, Antwerp, Belgium, September 24, 1994.

Chaired a session "The European Directive on Patient Package Inserts: Implications for the US", at the 30th Annual Meeting of the Drug Information Association, "Health care systems in transition: a challenge for innovation"., Washington DC, USA, June 5-9, 1994.

Convened the International Congress "Pharmacoeconomics", European Society for Clinical Pharmacy and European Society for Hospital Pharmacists, Gent, Belgium, May 18-20, 1994

Participated at the Symposium "Growing older : medical and social aspects" of the Department of Medicine, University of Gent, December 11, 1993.

Participated at the Drug Information Association Euro-meeting "Interfaces in drug discovery, development and use: Reappraisal in an era of change", London, United Kingdom, October 10- 13,1993.

Convened and organized the Heymans Institute Symposium "Pharmacoepidemiology in Belgium", 1th Annual Meeting of the Belgian Society for pharmacoepidemiology, Gent, Belgium, October 9, 1993

Convened and organized the Heymans Institute Symposium "From Belgian Patient Package Inserts to European User Package Leaflets.", Gent, Belgium, April 28, 1993.

Participated at the Drug Information Association Workshop "Patient information and education about prescription drugs". Washington, DC, USA, November 18-19, 1992.

Participated at the Drug Information Association Workshop "Non- complier or Non-responder ?". Bern, Switzerland, May 18-19, 1992.

Participated at the international symposium "The importance of therapeucic coverage". Pfizer, Basel, Switzerland, February 14, 1991.

Participated at the symposium "[European future of research in general practice]". Janssen Research Group, Beerse, Belgium, June 16, 1990.

Participated at the International Dialogue Conference "Improving drug safety - A joint responsability", RAD-AR Foundation, Wolsfsberg, Switzerland, April 17-20, 1990.

Participated at the Workshop "The impact of partial compliance on clinical trials", Drug Information Association, Philadelphia, USA, September 18-19, 1989. Participated at the 25th annual meeting of the Drug Information Association "Challenges of drug discovery, global development and marketing in the 1190s", Drug Information Association, Boston, USA, June 19-22, 1989.

Participated at the Internation Congres on Primary Health Care "Research Methods for Primary Health care", European General Practice Research Workshop, Antwerp, Belgium, October 21, 1988.

Convened and organized the symposium "Patient package inserts as a source of written drug information", Heymans Institute of Pharmacology, Gent, Belgium, September 26-28, 1988.

Organized the symposium "[Bio-ethics in the ninenties]", State Secretary of Health, Brussels, Belgium, May 21-22, 1987.

Participated at the First European Conference of Medical Libraries "Medical Libraries: cooperation and new technologies", European Association of Health Information and Libraries, Brussels, Belgium, October 22-25, 1986.

Chaired the Symposium "Learning to deal with scientific information", Belgian Fund for Scientific Research, Brussels, Belgium, November 8, 1985.


PRESENTATIONS, Robert H. VANDER STICHELE



Vander Stichele RH, Deschepper R, Communication about end-of-life decisions with patients dying at home: development of guidelines for general practitioners. WONCA Europe Regional Conference, Amsterdam, 1-4 June, 2004. (Poster)

Deschepper R, Vander Stichele R, Bernheim JL, Mortier F, Deliens L. Guidelines on end-of-life care and communication: Do they include the patients' point of view? 3th Research Forum of the European Association for Palliative Care, Stresa, Lago Maggiore, Italy, 3-6 June, 2004. (Poster)

Deschepper R, Vander Stichele R, Mortier F, Deliens L et al. Communication about end-of-life decisions with patients dying at home: development of guidelines for general practitioners, Vierde Eerstelijnssymposium: De patiënt centraal, WVVH, 27 September 2003. (Poster)

Vander Stichele RH. European Surveillance of antimicrobial Consumption: Quality Indicators. 6th Congress of the European Association of Clinical Pharmacology and Therapeutics, Istanbul, 24 - 28 June, 2003. (Poster)

Ferech M, Vander Stichele RH, Elsevier M, Goossens H. An exploration of the Therapeutic arsenals of antibiotics in European countries using the Drug Utilization 90% method. 6th Congress of the European Association of Clinical Pharmacology and Therapeutics, Istambul, 24 - 28 June, 2003. (Poster)

Elsevier M , Vander Stichele RH, Ferech M, Goossens H. Regional clusters in antibiotic consumption in Europe. 6th Congress of the European Association of Clinical Pharmacology and Therapeutics, Istanbul, 24 - 28 June, 2003. (Poster)

Vander Stichele RH, Elseviers M, Ferech M, Goossens H. Data collection performance in the European surveillance of antibiotic consumption. Results of the retrospective data collection 1997-2001. 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, UK, 10-13 May, 2003. (On invitation)

Ferech M, Elseviers M, Vander Stichele RH, Goossens H. Methodological problems encountered in the European surveillance of antibiotic consumption. Results of the retrospective data collection 1997-2001. 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, UK, 10-13 May, 2003. (On invitation)

Elseviers M, Ferech M, Vander Stichele RH, Goossens H. Consumption of antibiotics in ambulatory care in Europe: Results of the retrospective data collection 1997-2001. 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, UK, 10-13 May, 2003. (On invitation)

Elseviers M, Ferech M, Vander Stichele RH, Goossens H. Consumption of antibiotics in hospital care in Europe: Results of the retrospective data collection 1997-2001. 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, UK, 10-13 May, 2003. (On invitation)

Goossens H, Vander Stichele RH, Elseviers M, Ferech M. Consumption of antibiotics in [26 European countries]. Results of the retrospective data collection 1997-2001 (Poster session with 26 posters). 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, UK, 10-13 May, 2003.

Bernheim J, Deschepper R, Mortier F, Vander Stichele R, Deliens L. Information and Communication Agreements (ICA) to harmonise Patient autonomy and physician beneficence at the end of life. 8th Congress of the European Association for Palliative Care in The Hague, The Netherlands, 2-5 April, 2003. (Poster)

Deschepper R, Bernheim J, Ceulemans L, Mortier F, Van Der Kelen G, Vander Stichele R, Deliens L. Communication about end-of-life decisions with patients dying at home: development of guidelines for general practitioners. 8th Congress of the European Association for Palliative Care in The Hague, The Netherlands, 2-5 April, 2003. (Presentatie)

Van Der Kelen G, Deschepper R, Vander Stichele R, Bernheim J, Ceulemans L, Mortier F, Deliens L. The changing position of the general practitioner in the end-of-life care : The patient's perspective. 8th Congress of the European Association for Palliative Care in The Hague, The Netherlands, 2-5 April, 2003. (Poster)

Bilsen J, Vander Stichele R, Deliens L, Mortier F, Mortier E. Life-Terminating Drugs Used by Belgian Physicians in End-of-Life Decisions Not Requested by Terminal Patients. 18th International Conference on Pharmaco epidemiology, Edinburgh, 20-23 August, 2002. (Poster)

Ronning M, Blix HS, Strom H, Vander Stichele R, Andersen M, Skovlund E. Use of antibacterials in Europe: A study on collecting comparable National Drug Use data in Europe. 18th International Conference on Pharmaco epidemiology, Edinburgh, 20-23 August, 2002. (Poster)

Hejdova M, Gorecka K, Lindhartova A, Kucera Z, Zemkova M, Vlcek J, Vander Stichele R. Drug Utilization Studies at International Conferences of Pharmacoepidemiology, 1996-2001. 18th International Conference on Pharmaco epidemiology, Edinburgh, 20-23 August, 2002. (Presentation)

Elsevier M, Vander Stichele R, Hendrix E, Goossens H. A European funded project on antimicrobial consumption (ESAC): Availability and accessability of antibiotic consumption data in European countries. 18th International Conference on Pharmaco epidemiology, Edinburgh, 20-23 August, 2002. (Poster)

Vander Stichele R, Elsevier M, Hendrix E, Seys B, Goossens H. Comparing Belgian Antibiotic consumption data: methodological problems. 18th International Conference on Pharmaco epidemiology, Edinburgh, 20-23 August, 2002. (Poster)

Bernheim J, Cosyns M, De Bock R, De Grève J, Deliens L, Distelmans W, Mathys R, Mortier E, Mortier F, Schots E, Vander Stichele R. The patient-physician information contract: a solution to the dilemma between patient autonomy and physician paternalism, Winter Oncology Conference 7, Flims - Switserland, 21-27 january 2001. (Poster)

Vander Stichele RH. Co-operation between drug information centres (DICs) and Drug Utilization Research Groups (DURGs) on the national level. EuroDURG Meeting 2001, Prague, 7 - 9 June, 2001. (Presentatie)

De Schepper R, Vander Stichele RH. Different use of antibiotics in Europe: The role of cultural factors. EuroDURG Meeting 2001, Prague, 7 - 9 June, 2001. (Poster)

Vander Stichele RH, Bossens M, De Falleur M, Seys B, Elseviers M. Utilization of antibiotics in Belgium. EuroDURG Meeting 2001, Prague, 7 - 9 June, 2001. (Poster)

Vander Stichele RH, Meerschaut F, Blocklandt I, Wittouck E, Demaeseneer J. A pilot study of a community approach to the control of head lice infestation in 3 inner city primary schools in Belgium. EuroDURG Meeting 2001, Prague, 7 - 9 June, 2001. (Poster)

Vander Stichele R, Deliens L., Bilsen J, Deschepper R. Utilization of euthanatica in Belgium: results of a death certificate study. 16th International Conference on Pharmaco epidemiology, Barcelona, 20-23 August 2000. (Poster)

Deschepper R, Vander Stichele R. Antibiotics utilization and the cultural context - An antropological investigation of the lay perspective in a Dutch and a Belgian city. 16th International Conference on Pharmaco epidemiology, Barcelona, 20-23 August 2000. (poster)

Deschepper R, Vander Stichele R, Mortier F, Bilsen J. End-of-life decisions of clinical specialists and GP's in Belgium (Flanders). 3th Conference of death, dying and suicide, Stockholm, 28-30 August 2000. (Poster)

Vander Stichele RH. Dose omissions and their consequences. European Association of Clinical Pharmacology and Therapeutics, Jeruzalem, October 4-6, 1999.

Deliens L, Bilsen J, Cosyns M, Ingels K, Mortier F, Vander Stichele R, Handelwijzen van Hasseltse huisartsen rond het levenseinde van patiënten, in: congresbundel van de 17de VHI-referatendag, te Antwerpen, Vlaams Huisartsen Instituut, 25 September, 1999. (Poster)

Deliens L, Mortier F, Bilsen J, Cosyns M, Ingels I, Vander Stichele R, Attitudes and behaviour of physicians concerning end-of-life decisions, conference proceedings 15th Nordic Conference on Social Medicine, Reykjavík - Iceland, 3-5 Juni 1999. (Poster)

Bilsen J, Deliens L, Cosyns M, Ingels K, Mortier F, Vander Stichele R, The patient-doctor relationship in end-of-life decisions in Belgium, conference proceedings Annual Meeting of EUPHA, Göteborg - Sweden, 10-12 December 1998. (Poster)

Mortier F, Deliens L, Bilsen J, Cosyns M, Ingels K, Vander Stichele R, End-of-life acts of doctors in Belgium (Flanders): a research design for a national survey, conference proceedings 12th International Conference of the "World Federation of Right to Die Societies", Zürich, 12 ? 15 October 1998. (Poster)

Vander Stichele RH, De Vooght G, Lammertyn J, Reynvoet B, Vandierendonck A. Impact of benefit information in patient package inserts on patients' perception of risk/benefit of medicines. 14th International Conference on Pharmacoepidemiology, Berlin, 16-19 August, 1998. (Poster)

Deliens L, Bilsen J, Cosyns M, Ingels K, Mortier F, Vander Stichele R, End-of-life acts of GP's and specialists in Belgium, conference proceedings 15th WONCA World Conference, Dublin - Ireland, 14-18 Juni 1998. (Presention)

Deliens L, Bilsen J, Cosyns M, Ingels K, Mortier F, Vander Stichele R, Behaviour of doctors concerning the end-of-life of their patients. Results of a survey of 269 deaths in the city of Hasselt (Belgium), conference proceedings Annual Meeting of EUPHA, Pamplona - Spain, 20-22 November 1997. (Poster)

Presented "Collection and analysis of comprehensive data on Utilization of reimbursed medicines in Belgium" at the first European Drug Utilization Research Group Meeting, Lake Balaton, Hungary, June 29, 1996.

Presented "The influence of copayment and reimbursement policy on drug Utilization" at the University of Gent, 80st Continuing Medical Education Course, Gent, Belgium, June 5, 1996.

Presented "Compliance measurement, Data expression and analytical strategy : 5 delusions and 5 promises", at the University of Limburg, Departement of Epidemiology "Lowlands workshop on patient compliance", Maastricht, The Netherlands, May 13, 1996

Presented "Working with drug utilization monitoring data [Dutch]", at a joint symposium of the Scientific Association of the Flemisah General Practitioners and the Royal Association of Pharmacists of Antwerp "Analysing prescription behavior", Antwerp, Belgium, February 10, 1996

Presented "The prescription of medicines and the pharmacist- physician interaction", at the IVth European Forum for Pharmaceutical education, Brussels, Belgium, December 11, 1995.

Presented "Drug Utilization in the Elderly", at the 1st Congress of the European Association for Clinical Pharmacology and Therapeutics, Paris, France, September 28, 1995 (With Bogaert MG)

Presented "Side effects of medicines and partial compliance : two related impediments to the quality of prescription drug therapy", at the 31th annual Meeting of the Drug Information Association "The changing regulatory environment and its impact on global healthcare", Orlando, Florida, USA, June 25-29, 1995.

Prestented "The life of a drug : from birth to obsolence", at IBC-Conference, "New drug safety guidelines,: collecting the information, taking the right decision", Brussels, Belgium, April 25, 1995.

Presented "Investigator views and experience regarding "guidelines for retention of clinical trial records at investigator sites", at the Second Annual Conference of the European Forum for Good Clinical Practice,."Common sense in GCP - an EFGCP debate -". Brussels, Belgium, March 29, 1995.

Presented "Medication Utilization, information and expenditure of frail elderly living at home", 2th annual Meeting of the Belgian Society for Pharmaco-epidemiology, Brussels, Belgium, November 19, 1994

Presented "Attitude of health Professionals towards patient package inserts", 30th Annual Meeting of the Drug Information Association, "Health care systems in transition: a challenge for innovation"., Washington DC, USA, June 5-9, 1994.

Presented "How to influence prescribing by primary care physicians?", International Congress "Pharmacoeconomics", Gent, Belgium, May 18-20, 1994.

Presented "Drug Utilization Evaluation: the contribution of the community pharmacists to the control of expenditures for pharmaceuticals. International Congress "Pharmacoeconomics", Gent, Belgium, May 18-20, 1994

Co-presented "Drug treatment: risk perception by the public and the health professionels" at the 8th international conference of Pharmaceutical Medicine,"Drug developement in the nineties: a global commitment". Rome, Italy, April 27-29, 1994 (with Bogaert MG).

Presented "Prescription patterns in general practice and attitudes of family physicians towards written medication information", at a workshop of the Dutch Institute of Pharmaceutical marketing, Gent, Belgium, December 16, 1993 [Dutch].

Co-presented "The elderly and medication utilization and information" at a symposium of the Departement of Medicine, Gent, Belgium, December 11, 1993 (with Bogaert MG) [Dutch].

Presented "Participation of general practitioners in clinical trials", at a symposium of the Flemish Research Institute of General Practice, october 26, 1993 [Dutch].

Presented "European legislation and research projects regarding patient education for medication" at the Euro-DIA meeting, October 12, 1993.

Co-presented "The use of K-Dimensional computer storage and retrieval Systems for pharmacoepidemiological analysis of billing data on reimbursed medication in Belgium" at the Heymans Institute Symposium "Pharmacoepidemiology in Belgium", Gent, Belgium, October 9, 1993 (with P. Lehert). Presented "Utilization of subsidized and nonsubsidized reimbursable peptic ulcer medication in Belgium" at the Heymans Institute Symposium "Pharmacoepidemiology in Belgium", Gent, Belgium, October 9, 1993 (with H. Petri).

Presented "Medication information and utilization among socially active elderly", at the Annual Meeting of the Flemish Research Institute, Gent, Belgium, September 18, 1993 [Dutch].

Co-presented "The impact of the European Community's 1992 regulations on patient information through the package leaflet", at the annual meeting of the Royal Society of Medicine, London, United Kingdom, September 16, 1993 (with MG. Bogaert).

Presented "Time intervals between medication events: an approach to measurement of patient compliance with data from electronic monitoring" at a seminar in the University of Limburg, Statistical department, Diepenbeek, Belgium, September 9, 1993.

Presented "Belgian and European research projects on patient package inserts", at the Heymans Institute Symposium "From Belgian Patient Package Inserts to European User Package Leaflets.", Gent, Belgium, April 28, 1993.

Presented "Computerized readability control of patient package inserts in Belgium" at the 3rd Computer Workshop "Information technology for the registration and surveillance of medicinal products", organized by the Regulatory Affairs Professionals Society Europe and the Commission of the European Community, Brussels, Belgium, February 23-24, 1993 (with MG. Bogaert).

Presented "Patient compliance and therapeutic coverage: implications of the pharmacokinetics of amlodipine." at a satellite symposium of the 12th annual scientific meeting of the Belgian Society of Cardiology, Brussels, Belgium, February 4, 1993.

Presented "1994 EEC regulations: plans and research experiences with patient information and education" at the Food and Drug Administration, Center for drug evaluation and research, Advanced Scientific Education Seminar, Rockville, Maryland, USA, November 20, 1992.

Presented "Review and update on European initiatives regarding patient education for medication" at the Drug Information Association Workshop, Washington, DC, USA, November 18, 1992.

Presented "Studies of the interface between primary care and hospital care in drug utilization" at the Annual Meeting of the Flemisch Association of Hospital Pharmacists, Gent, Belgium, April 28, 1992.

Presented "New medications to face the reality of pharmacotherapy in general practice." for Phizer, Finland, in Brussels, Belgium, March 27, 1992.

Presented "Impact of Patient Package Inserts on Patients' Satisfaction, Adverse Drug Reactions and Risk Perception: The Case of NSAIDs for posttraumatic Pain Relief" at the Annual Meeting of the Flemish Research Institute of Family Practice, Kortrijk, Belgium, June 15, 1991.

Presented "Network of Patchwork? Citation Analysis of 6 international Research Journals in Family Medicine" at the Annual Meeting of the Flemish Research Institute of Family Practice, Kortrijk, Belgium, June 15, 1991.

Presented "Written drug information in patient package inserts; the Belgian drug information program and evalutation research project" at the Continuing Medical Education Course of Clinical Pharmacology, University of Louvain, Belgium, March 14, 1991.

Presented "New medications to face the reality of pharmaco- therapeutics in General Practice" to a Pfizer symposium, Basel, Switzerland, Februari 14, 1991.

Presented "General practitioner and pharmacist: the role of primary health care clinicians in clinical research" at a symposium of the Royal Association of Pharmacists of Antwerp, Belgium, October 24, 1990.

Presented "Fitting research in general practice into Good Clinical Practice" to the symposium of the Janssen Research Group, Beerse, Belgium, June 16, 1990.

Presented "A carrier of consensus on medication information : the patient package insert" at the International Dialogue Conference of the RAD-AR Foundation, Wolsfsberg, Switzerland, April 17-20, 1990. Presented "Patient package inserts: the Belgian experience with a mandatory progrma" at the 25th annual meeting of the Drug Information Association, Boston, USA, June 19-22, 1989.

Presented "Action research and medical documentation in primary health care" at the International Congres on Primary Health Care of the European General Practice Research Workshop, Antwerp, Belgium, October 21, 1988.

Presented "Patient package inserts as a source of drug information: review of the literature" at the symposium of the Heymans Institute of Pharmacology, Gent, Belgium, September 26- 28, 1988.

Presented "A training course in medical documentation for family physicians" to the first European Conference of the European Association of Health Information and Libraries, Brussels, Belgium, October 22-25, 1986.

Presented "Citation-analysis of family medicine literature" at the 5th annual meeting of the Flemish Research Institute of Family Medicine, Brussels, Belgium, April 19, 1986.

Presented "Learning to deal with scientific information: con- cluding remarks" to the symposium of the Belgian Fund for Scientific Research, Brussels, Belgium, November 8, 1985.




Scientific awards



1992 Upjohn Award for best flemish general practice research article in the international literature (see: Patient Education and Counseling, 1991).


Preferred quotes


Science must be explained as simple as possible, but not simpler.
Albert Einstein

L'homme a inventé la parole pour cacher ses idé es.
De Talleyrand

If I have seen further, it is by standing on the shoulders of giants.
Isaac Newton

If I have not seen further, it is by standing in the footprints of giants.
Unknown student

The nice thing about standards is that there are so many to choose from.
Andy Tanebaum